The CETSA Explore: A tool to discover the drugs of tomorrow
20 Feb 2023
In this video, Pelago describes how the CETSA® Explore, a proteome wide mass spectrometry-based detection method, is ideal for mechanism of action investigations, phenotypic target deconvolution, safety assessments, and more.
About the company
Pelago Bioscience
Pelago Bioscience was founded in 2013 with the aim to develop the patented Cellular Thermal Shift Assay (CETSA®) for maximum utility and customer value in drug discovery and diagnostics. Today, Pelago Bioscience is a Drug Discovery Research Partner supporting preclinical drug discovery and development. Pelago offer a range of services, from confirming target engagement to strengthening target validation and understanding the mechanism of action of your compounds. The approach is designed to help you make better decisions faster.
